Beam Therapeutics Inc. Common Stock (BEAM) Sentiment
SentiSense Score 100 · Bullish · ▬ steady · as of 2026-06-25
BEAM sentiment is strong bullish (SentiSense Score 100, holding near its 30-day average of 39); attention is steady (1 mentions).
- Sentiment
- Strong Bullish
- SentiSense Score
- 100
- Mentions
- 1
Sentiment by source
- News
- Bullish
- Neutral
What's driving it
- FDA Clears Gene Therapy Trial for Phenylketonuria (PKU) (+0.78)
- Beam Therapeutics Advances Phase 1/2 Trial for AAT Deficiency with Gene-Editing Therapy (+1)
Live SentiSense Score, sentiment history, and per-source breakdown for Beam Therapeutics Inc. Common Stock on SentiSense.